ASGCT Annual Meeting 2025
We connect specialty therapies to the patients who need them most by delivering modern, customized solutions in access, safety, and evidence generation. Our experts bring ample first-hand knowledge to gene and cell therapy with almost 40 programs delivered to date. This unique depth of experience enables us to tailor each program to your product and patient requirements.
Connect with our attending team members by completing the form at the right to get in touch. To learn more, click here.
Meet Us There
To use these forms you must accept all cookies
Learn More About UBC
We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.
Other Events
Trade & Channel Strategies 2026
Operationalise: Early Access Programmes Summit Europe 2026
ASH Annual Meeting 2026
Meet Us There
Thank You for Connecting with UBC
.
What You Can Expect Next
.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.